Sensei Biotherapeutics, Inc.
SNSE
$12.63
-$0.37-2.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 606.31% | 20.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3,342.14% | 2.19% | |||
| Operating Income | -3,342.14% | -2.19% | |||
| Income Before Tax | -3,508.99% | -3.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3,508.99% | -3.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3,508.99% | -3.24% | |||
| EBIT | -3,342.14% | -2.19% | |||
| EBITDA | -3,365.31% | -2.20% | |||
| EPS Basic | -3,415.11% | -3.23% | |||
| Normalized Basic EPS | -3,319.43% | -6.21% | |||
| EPS Diluted | -3,415.11% | -3.23% | |||
| Normalized Diluted EPS | -3,319.43% | -6.21% | |||
| Average Basic Shares Outstanding | 2.67% | 0.01% | |||
| Average Diluted Shares Outstanding | 2.67% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||